Overview

Bioequivalence Study of 4 mg Glimepiride Tablet

Status:
Completed

Trial end date:
2011-03-01

Target enrollment:

Participant gender:

Summary

This was a randomized, single blind, two-period, two sequence cross-over study under fasting condition to compare the bioavailability of two glimepiride 4 mg tablet formulations (test and reference formulations).

Phase:

N/A

Details

Lead Sponsor:

Dexa Medica Group

Treatments:

Glimepiride